RESISTANT CANCER
Clinical trials for RESISTANT CANCER explained in plain language.
Never miss a new study
Get alerted when new RESISTANT CANCER trials appear
Sign up with your email to follow new studies for RESISTANT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on Hard-to-Treat breast cancer
Disease control Recruiting nowThis early-stage study tests a new treatment for triple negative breast cancer that has come back or not responded to other therapies. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goal is to che…
Matched conditions: RESISTANT CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 16, 2026 22:32 UTC
-
Engineered immune cells take on tough pancreatic cancer
Disease control Recruiting nowThis study tests a new gene therapy for people with pancreatic cancer that has returned after standard treatment. The therapy uses the patient's own immune cells, modified to target a protein called B7-H3 on cancer cells, and includes a safety switch to control side effects. The …
Matched conditions: RESISTANT CANCER
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC